Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Nov-Dec;19(6):427-30.
doi: 10.1007/BF01726455.

Antibody prevalence of parenterally transmitted viruses (HIV-1, HTLV-I, HBV, HCV) in Austrian intravenous drug users

J Pont  1 , C Neuwald, G Salzner
Affiliations

Antibody prevalence of parenterally transmitted viruses (HIV-1, HTLV-I, HBV, HCV) in Austrian intravenous drug users

J Pont et al. Infection. 1991 Nov-Dec.

Abstract

From 1985 to 1990 the sera of 372 newly imprisoned intravenous drug users (IDU) were tested for HIV-1 antibodies. The seroprevalence was 18%, males 16% and females 31%. HIV-1 seroprevalence in Austrian IDU has not increased since 1986. All sera tested for HTLV-I-antibodies were negative. The majority of the HIV-1 seropositive drug users had been infected before 1985. The reported frequency of needle sharing has decreased since 1986. Of 151 IDU tested for HCV antibodies 75% were positive for anti-HCV, 68% were positive for hepatitis B markers, 59% were positive for both HBV and HCV markers, and 13% were positive for HIV-1 antibodies.

In conclusion: in Austrian IDU HCV seems to be the most frequent parenterally transmitted virus; HIV-1 seroprevalence has not increased since 1986; HLTV-I infection has not yet begun.

PubMed Disclaimer

References

    1. Lancet. 1985 Aug 24;2(8452):449-50 - PubMed
    1. AIDS Forsch. 1987 Jun;(6):323-34 - PubMed
    1. Wien Klin Wochenschr. 1986 Jul 18;98(14):454-7 - PubMed
    1. Lancet. 1985 Jul 6;2(8445):52-3 - PubMed
    1. J Acquir Immune Defic Syndr. 1988;1(2):163-4 - PubMed